An immunomodulating anti-rheumatic drug, lobenzarit disodium (CCA): inhibition of polyclonal B-cell activation and prevention of autoimmune disease in MRL/Mp-lpr/lpr mice (Q68832548)
Jump to navigation
Jump to search
scientific article published on 01 December 1987
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An immunomodulating anti-rheumatic drug, lobenzarit disodium (CCA): inhibition of polyclonal B-cell activation and prevention of autoimmune disease in MRL/Mp-lpr/lpr mice |
scientific article published on 01 December 1987 |
Statements
An immunomodulating anti-rheumatic drug, lobenzarit disodium (CCA): inhibition of polyclonal B-cell activation and prevention of autoimmune disease in MRL/Mp-lpr/lpr mice (English)
M Mihara
T Nakano
1 December 1987